The primary objective was to assess the effect of 3-month treatment of low and standard doses
of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels
in patients with type 2 diabetes and dyslipidemia.
Minimum age: 20 Years.
Maximum age: 80 Years.
Gender(s): Both.
Site 201, Katowice, Poland
Site 202, Warszawa, Poland
Site 203, Katowice, Poland
Site 204, Zabrze, Poland
Site 101, Kyiv, Ukraine
Site 102, Kyiv, Ukraine
Site 103, Kyiv, Ukraine
Site 104, Kyiv, Ukraine
Site 105, Kyiv, Ukraine
Site 106, Kyiv, Ukraine
Site 107, Kyiv, Ukraine
Site 108, Kharkiv, Ukraine
Site 109, Kharkiv, Ukraine
Site 111, Dnipropetrovsk, Ukraine
Site 112, Zaporizhya, Ukraine
Site 113, Dnipropetrovsk, Ukraine
Site 1, Frome, United Kingdom
Site 2, South Glamorgan, United Kingdom
Site 3, Paignton, United Kingdom
Site 4, Ely, United Kingdom
Site 5, Hastings, United Kingdom
Site 6, Soham, United Kingdom
Site 7, Randalstown, United Kingdom
Site 8, Bexhill-on-Sea, United Kingdom
Site 9, Kingswood, United Kingdom
Site 10, Chippenham, United Kingdom
Site 11, Fife, United Kingdom
Site 12, Petersborough, United Kingdom
Site 13, Coventry, United Kingdom
Site 14, Balsall Common, United Kingdom
Site 15, Downpatrick, United Kingdom
Site 16, Harrow, United Kingdom
Site 17, Ely, United Kingdom
Site 18, Yaxley, United Kingdom
Site 19, Keresley end, United Kingdom
Site 20, Camberley, United Kingdom
Site 21, Atherstone, United Kingdom
Site 22, Chesterfield, United Kingdom
Site 23, Barry, United Kingdom
Site 25, Newtownabbey, United Kingdom
Site 26, Haverfordwest, United Kingdom
Site 27, Slough, United Kingdom
Site 28, Odiham, United Kingdom
Site 29, Swindon, United Kingdom
Site 30, Trowbridge, United Kingdom
Site 31, Doncaster, United Kingdom
Site 32, Bangor, United Kingdom
Site 33, Northampton, United Kingdom
Site 34, Stratford on Avon, United Kingdom
Site 35, Acomb, United Kingdom
Site 36, Basingstoke, United Kingdom